BRD2 and Osteopenia: This hypothesis was supported by the findings that hypogonadic mice lacking either the FSH receptor (Fshr−/−) or the FSH ß-subunit (Fshb−/−) failed to develop the expected osteopenia, and that FSH administration activated osteoclast differentiation in vitro[8].